On going treatment(s)-Bone marrow transplant Posts on Medivizor
Navigation Menu

On going treatment(s)-Bone marrow transplant Posts on Medivizor

How useful is bortezomib maintenance after allogeneic stem cell transplant in young or high-risk patients with multiple myeloma?

How useful is bortezomib maintenance after allogeneic stem cell transplant in young or high-risk patients with multiple myeloma?

Posted by on Jan 23, 2022 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the use of bortezomib (BTZ; Velcade) maintenance after allogeneic hematopoietic cell transplant (alloHCT) for improving relapse and chronic graft versus host disease (cGVHD) in patients with multiple myeloma (MM) that are young or high-risk. The data showed that BTZ maintenance is effective and safe in...

Read More

How do bortezomib, thalidomide, dexamethasone and daratumumab impact the quality of life of patients with multiple myeloma?

How do bortezomib, thalidomide,  dexamethasone and daratumumab impact the quality of life of patients with multiple myeloma?

Posted by on Feb 26, 2021 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the health-related quality of life of patients with multiple myeloma (MM) after treatment with VTd (bortezomib, thalidomide, and dexamethasone) with or without daratumumab (D; Darzalex). The study found that all patients that received treatment had an improved quality of life, while...

Read More

What are the long-term outcomes after plerixafor and G-CSF before stem cell transplantation?

Posted by on Mar 8, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the long-term outcomes of patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM) who received plerixafor (Mozobil) or placebo combined with G-CSF (granulocyte colony stimulating factor) before a stem cell transplant (SCT). This study concluded that adding plerixafor to G-CSF did not negatively...

Read More

What are the long-term outcomes after plerixafor and G-CSF before stem cell transplantation?

Posted by on Mar 8, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the long-term outcomes of patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM) who received plerixafor (Mozobil) or placebo combined with G-CSF (granulocyte colony stimulating factor) before a stem cell transplant (SCT). This study concluded that adding plerixafor to G-CSF did not negatively...

Read More

What are the outcomes of reduced intensity alloSCT in MCL patients?

Posted by on Jan 27, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the long-term outcomes of MCL (mantle cell lymphoma) patients who received RIST (reduced-intensity allogenic stem cell transplant) therapy. The authors concluded that RIST may be curative in MCL patients, even in those who relapsed after autoSCT (autologous stem cell transplant). Some background Mantle cell...

Read More

Early stem cell transplantation may improve survival rates for patients with follicular lymphoma whose first-line chemotherapy failed

Posted by on Jan 13, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of autologous stem cell transplantation (auto-SCT) on patients with follicular lymphoma who have disease progression within 2 years of initial chemotherapy. The study found that patients who receive early auto-SCT have better survival rates than patients who do not receive auto-SCT.  Some background...

Read More

The effectiveness of radiotherapy following autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Posted by on Dec 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of radiotherapy after autologous stem cell transplantation for patients with relapsed or difficult to treat diffuse large B-cell lymphoma. The study concluded that patients had better tumor control when treated with involved-field radiotherapy after autologous stem cell transplantation.  Some...

Read More

Upfront autologous stem cell transplantation treatment for patients with high-risk diffuse large B-cell lymphoma

Posted by on Nov 18, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effectiveness of autologous stem cell transplantation after their first remission for patients with high-risk diffuse large B-cell lymphoma. The study concluded that patients who received autologous stem cell transplantation had better outcomes than those who did not. Some background Diffuse large B-cell...

Read More

Autologous stem cell transplantation in patients with mantle cell lymphoma

Posted by on Oct 12, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study compared the effectiveness of autologous stem cell transplantation in patients with mantle cell lymphoma who either did or did not achieve a complete response after first line treatment. The study concluded that autologous stem cell transplantation is most useful for patients who have already achieved a complete...

Read More